MXPA05008219A - Composiciones y metodos para tratar condiciones de la piel. - Google Patents

Composiciones y metodos para tratar condiciones de la piel.

Info

Publication number
MXPA05008219A
MXPA05008219A MXPA05008219A MXPA05008219A MXPA05008219A MX PA05008219 A MXPA05008219 A MX PA05008219A MX PA05008219 A MXPA05008219 A MX PA05008219A MX PA05008219 A MXPA05008219 A MX PA05008219A MX PA05008219 A MXPA05008219 A MX PA05008219A
Authority
MX
Mexico
Prior art keywords
compositions
methods
skin conditions
treating skin
pih
Prior art date
Application number
MXPA05008219A
Other languages
English (en)
Spanish (es)
Inventor
Glenn Nystrand
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/903,702 external-priority patent/US8106094B2/en
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA05008219A publication Critical patent/MXPA05008219A/es

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA05008219A 2004-07-30 2005-08-01 Composiciones y metodos para tratar condiciones de la piel. MXPA05008219A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/903,702 US8106094B2 (en) 1998-07-06 2004-07-30 Compositions and methods for treating skin conditions

Publications (1)

Publication Number Publication Date
MXPA05008219A true MXPA05008219A (es) 2006-02-01

Family

ID=35767558

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008219A MXPA05008219A (es) 2004-07-30 2005-08-01 Composiciones y metodos para tratar condiciones de la piel.

Country Status (6)

Country Link
JP (1) JP2006045229A (pt)
KR (1) KR20060048931A (pt)
AU (1) AU2005203301A1 (pt)
BR (1) BRPI0503227A (pt)
CA (1) CA2513936C (pt)
MX (1) MXPA05008219A (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2722691A1 (fr) * 1994-07-22 1996-01-26 Oreal Composition cosmetique et/ou dermatologique conten lutter contre l'acne ou le vieillissement ant de l'eau thermale ou minerale et un actif pour
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
ES2375703T3 (es) * 1999-11-05 2012-03-05 Johnson & Johnson Consumer Companies, Inc. Composiciones despigmentantes a base de soja para el cuidado de la piel.
JP4612180B2 (ja) * 2000-12-19 2011-01-12 株式会社ヤクルト本社 皮膚外用剤
US6680062B2 (en) * 2001-10-05 2004-01-20 Color Access, Inc. Anti-irritating rosacea treatment

Also Published As

Publication number Publication date
KR20060048931A (ko) 2006-05-18
CA2513936A1 (en) 2006-01-30
JP2006045229A (ja) 2006-02-16
AU2005203301A1 (en) 2006-02-16
BRPI0503227A (pt) 2006-05-16
CA2513936C (en) 2014-03-18

Similar Documents

Publication Publication Date Title
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
TW200640475A (en) Cosmetic and cosmeceutical compositions for restoration of skin barrier function
MX2010006370A (es) Composiciones de activo antitranspirante que tienen un cromatograma sec que exhibe una intensidad de pico 4 sec elevada.
WO2007133721A3 (en) Food compositions and methods of treating periodontal disease
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
WO2007073505A3 (en) Trpa1 inhibitors for treating pain
WO2005051358A8 (en) Composition and method for enhancing bioavailability
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
MXPA00007388A (es) Metodos para tratar la pigmentacion de la piel.
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MX2008002278A (es) Acido graso de aceite de bogol bajo en azufre.
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
EA200701995A1 (ru) Способы уменьшения кальцификации
PL1765270T3 (pl) Ulepszenia w kompozycjach lub dotyczące kompozycji do depilacji
TW200719920A (en) Topical skin care composition
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
RS20070095A (en) Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
WO2007079312A3 (en) Compositions and methods for treating actin-mediated medical conditions
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
AR048167A1 (es) Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio
PL1638582T3 (pl) Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej
TW200715997A (en) Method for prevention of formation of abnormal odor in beverage composition
MXPA05008219A (es) Composiciones y metodos para tratar condiciones de la piel.
MX2007013449A (es) Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo.